Successful treatment of metastatic thymic carcinoma with cisplatin, vinblastine, bleomycin, and etoposide chemotherapy
- 15 November 1990
- Vol. 66 (10) , 2092-2094
- https://doi.org/10.1002/1097-0142(19901115)66:10<2092::aid-cncr2820661008>3.0.co;2-1
Abstract
Thymic carcinomas are rare malignant neoplasms of the thymic epithelium that are distinguished from the malignant thymomas by the presence of cytologic atypia. Thymic carcinomas may metastasize outside of the thorax and are associated with a very poor prognosis. Complete responses of thymic carcinoma to chemotherapy alone have not been reported. A 21-year-old man with metastatic undifferentiated carcinoma of probable thymic origin is presented who achieved a pathologic complete response with cisplatin, vinblastine, and bleomycin chemotherapy. Additional consolidative chemotherapy with cisplatin and etoposide was administered. the patient remains disease-free 5 years after diagnosis. Cisplatin, vinblastine, and bleomycin chemotherapy appears to have significant activity against thymic carcinoma.This publication has 21 references indexed in Scilit:
- Thymic CarcinomaSouthern Medical Journal, 1988
- Thymic Epithelial NeoplasmsSouthern Medical Journal, 1985
- Association of Epstein–Barr Virus with Thymic CarcinomaNew England Journal of Medicine, 1985
- Thymoma and thymic carcinomaVirchows Archiv, 1985
- Primary thymic carcinomasThe American Journal of Surgical Pathology, 1982
- Thymic carcinomaThe American Journal of Surgical Pathology, 1982
- Treatment of invasive or metastatic thymoma: Report of eleven casesCancer, 1981
- Combination chemotherapy in invasive thymoma. Role of COPPCancer, 1980
- Thymic hyperplasia and neoplasia: A review of current conceptsHuman Pathology, 1978
- Chemotherapy of invasive thymomaCancer, 1976